Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
26 hedge funds and large institutions have $58.1M invested in Enzymotec Ltd in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
27% more capital invested
Capital invested by funds: $45.8M → $58.1M (+$12.3M)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
19% less funds holding
Funds holding: 32 → 26 (-6)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$1.04M |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$331K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$289K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$213K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$212K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Goldman Sachs
New York
| – | -$1.04M | -158,803 | Closed |
|
|
AG
27
Algert Global
San Francisco,
California
| – | -$331K | -50,566 | Closed |
|
|
GCP
28
GSA Capital Partners
London,
United Kingdom
| – | -$74K | -11,300 | Closed |
|
29
JP Morgan Chase
New York
| – | -$38K | -5,760 | Closed |
|
30
Morgan Stanley
New York
| – | -$35K | -5,311 | Closed |
|
|
CLOS
31
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$26K | -4,000 | Closed |
|
32
Creative Planning
Overland Park,
Kansas
| – | -$1K | -200 | Closed |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$68 | +8 | New |
|
ENZY Hedge Fund Activity: Q1 2017 in Review
26 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q1 2017, worth a combined $58.1M — up 27% from $45.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ENZY and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Acadian Asset Management, adding an estimated $62K. The largest seller was Goldman Sachs, exiting entirely with an estimated $1.04M sold.
- 26 institutional investors held Enzymotec Ltd (ENZY) as of Q1 2017, down from 32 in Q4 2016.
- Funds reported $58.1M of Enzymotec Ltd stock for Q1 2017, up 27% quarter-over-quarter.
- 2 funds opened new Enzymotec Ltd positions in Q1 2017 and 7 closed out, a net change of -5 holders.
- The largest Enzymotec Ltd buyer in Q1 2017 was Acadian Asset Management, an estimated $62K added.
- The largest Enzymotec Ltd seller in Q1 2017 was Goldman Sachs, an estimated $1.04M sold.
Based on aggregated 13F filings for Q1 2017.